Table 2.
Patient understanding of chemotherapy goals of care, adverse effects, financial costs, and logistics
| Learning preference | Goals of care | Adverse effects | Financial costs | Logistics | ||||
|---|---|---|---|---|---|---|---|---|
| Overall | Subgroup | Overall | Subgroup | Overall | Subgroup | Overall | Subgroup | |
| Who did the patients best understand? | Oncologist, 60% |
Men Oncologist, 56% Nursing staff, 56% Second regimen Oncologist, 60% Nursing staff, 60% |
Nursing staff, 66% |
First regimen Oncologist, 59% Second regimen Oncologist, 60% Nursing staff, 60% Third regimen Oncologist, 88% Age 25–44 y Oncologist, 100% |
Website or other resource, 13% |
Men Nursing staff, 30% Website or other resource, 30% Women Pharmacists, 25% Pamphlets, 25% Website or other resource, 25% First regimen Pamphlets, 38% Second regimen Nursing staff, 29% Pharmacist, 29% Website or other resource, 29% Third regimen Pharmacist, 50% Age 45–64 y Pamphlets, 40% Age 65–74 y Nursing staff, 22% Pharmacist, 22% Pamphlets, 22% Website or other resource, 22% Age ≥ 75 y Nursing staff, 25% Pharmacist, 25% Website or other resource, 25% Bachelor’s degree Nursing staff, 50% Graduate degree Pharmacist, 66% |
Oncologist, 61% |
Men Oncologist, 56% Nursing staff, 56% First regimen Nursing staff, 57% Age 25–44 y Oncologist, 50% Chemotherapy class, 50% Graduate degree Oncologist, 67% Nursing staff, 67% |
| Who did patients want information from? | Oncologist, 70% | NA | Nursing staff, 56% |
First regimen Oncologist, 80% Second regimen Oncologist, 71% Third regimen Oncologist, 100% Age 25–44 y Oncologist, 100% Age 65–74 y Oncologist, 56% Nursing staff, 56% |
Oncologist, 13% |
Men Oncologist, 18% Nursing staff, 18% Pamphlets, 18% Website or other resource, 18% Women Oncologist, 31% Chemotherapy class, 31% First regimen Chemotherapy class, 40% Second regimen Nursing staff, 29% Pharmacist, 29% Third regimen Oncologist, 33% Pharmacist, 33% Age 45–64 y Nursing staff, 38% Age 65–74 y Nursing staff, 30% Age ≥ 75 y Oncologist, 29% Website or other resource, 29% High school degree Oncologist, 24% Website or other resource, 24% Bachelor’s degree Nursing staff, 40% Graduate degree Oncologist, 33% Pharmacist, 33% Website or other resource, 33% |
Oncologist, 61% |
Age 25–44 y Oncologist, 50% Chemotherapy class, 50% Age 45–64 y Nursing staff, 67% Graduate degree Nursing staff, 80% |
| When was information provided? | During oncologist visit, 52% |
Men During oncologist visit, 56% Immediately before treatment began, 56% Age 25–44 y Immediately after diagnosis, 50% During oncologist visit, 50% Age 65–74 y Immediately before treatment began, 59% |
During oncologist visit, 50% |
Women Immediately before treatment began, 48% Second regimen Immediately before treatment began, 53% Age 25–44 y Immediately after diagnosis, 50% During oncologist visit, 50% Age 45–64 y Immediately before treatment began, 57% Age 65–74 y During oncologist visit, 59% Immediately before treatment began, 59% Graduate degree During oncologist visit, 50% Immediately before treatment began, 50% |
During oncologist visit, 20% |
First regimen Immediately before treatment began, 67% Age 65–74 y Immediately after diagnosis, 43% During oncologist visit, 43% High school degree During oncologist visit, 40% Immediately before treatment began, 40% |
During oncologist visit, 61% |
Age 25–44 y Immediately after diagnosis, 50% Immediately before treatment began, 50% Bachelor’s degree During oncologist visit, 45% Immediately before treatment began, 45% |
| When did patients want information provided? | During oncologist visit, 52% |
Second regimen Immediately before treatment began, 47% Age 25–44 y Immediately after diagnosis, 50% During oncologist visit, 50% Age 65–74 y During oncologist visit, 53% Immediately before treatment began, 53% |
During oncologist visit, 48% |
Women Immediately before treatment began, 52% Second regimen Immediately before treatment began, 47% Age 25–44 y Immediately after diagnosis, 50% During oncologist visit, 50% Age 65–74 y Immediately before treatment began, 65% Age ≥ 75 y Immediately after diagnosis, 38% During oncologist visit, 38% |
During oncologist visit, 30% |
Second regimen Immediately after diagnosis, 50% During oncologist visit, 50% Age ≥ 75 y Immediately after diagnosis, 33% During oncologist visit, 33% |
During oncologist visit, 55% |
Age 25–44 y Immediately after diagnosis, 50% Immediately before treatment began, 50% |
NA, not applicable